Yuhan Corporation (KOSE: A000100)
Health Care · Pharmaceuticals · KR
₩74,100.00
-2.37% today · -38.6% 1Y
Yuhan Corporation (KOSE: A000100) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.11B.
Over the last twelve months the share price has lost 38.6%, trading between 65.00K and 129.20K.
Tweenvest scores Yuhan Corporation across four factors: quality 76/100, value 63/100, growth 51/100, dividend 14/100. Its strongest factor is quality.
A000100 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.11B
- Revenue (TTM)
- $1.47B
- P/E
- 23.60
- EPS
- 3,139.61
- Dividend yield
- 0.81%
- Beta (5Y)
- 0.43
- 52-week high
- ₩129,200.00
- 52-week low
- ₩65,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 74.76M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.30B | CN¥71.83 | +1.81% |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.30B | $39.23 | -0.86% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.26B | $35.45 | -1.88% |
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.26B | R160.00 | +1.90% |
| J. B. Chemicals & Pharmaceuticals LimitedBSE: 506943 | $4.02B | Rs— | — |
| Caliway Biopharmaceuticals Co., Ltd.TWSE: 6919 | $3.90B | NT$79.90 | -0.25% |
| Hypera S.A.BOVESPA: HYPE3 | $3.85B | R$27.32 | +1.19% |
| Emcure Pharmaceuticals LimitedNSEI: EMCURE | $3.83B | Rs1,944.60 | -0.31% |
Figures last refreshed Oct 4, 2026.